Shuanghong Zhu

#79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes.

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes.

Journal: Experimental hematology & oncology

Published: October 25, 2024

Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Journal: Hematological oncology

Published: July 25, 2024

RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells.

RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells.

Journal: Science advances

Published: April 17, 2024

The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms.

The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms.

Journal: Leukemia

Published: October 07, 2023

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Journal: American journal of hematology

Published: September 20, 2023

Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes.

Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes.

Journal: The Journal of clinical investigation

Published: May 26, 2023

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex.

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex.

Journal: British journal of cancer

Published: February 26, 2022

Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes.

Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes.

Journal: Journal of cancer research and clinical oncology

Published: June 08, 2021

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes.

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes.

Journal: American journal of cancer research

Published: September 02, 2020

TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.

TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.

Journal: Asia-Pacific journal of clinical oncology

Published: August 08, 2019

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.

Journal: Cancer science

Published: March 16, 2019

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.

Journal: Haematologica

Published: May 15, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026